Moreover, plasma ALT levels were significantly reduced in mice treated with Cpd17 compared with MCD‐diet‐fed NASH mice, further suggesting Cpd17 significantly improved liver function (Fig 7C). This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.